10-Q

Company

Cellectar Biosciences, Inc.

Filed

November 18, 2024

Period of Report

September 30, 2024

Accession Number

0001410578-24-002012

A 10-Q is a quarterly financial report filed after each of the first three quarters of a fiscal year. It includes unaudited financial statements and management commentary. Learn more about 10-Q filings →